Q1 2016 13F Holders as of 3/31/2016
    
   
  
    
    
      
- 
        Type / Class
      
- 
        Equity / Common Stock
      
      
- 
        Shares outstanding
      
- 
        146M
      
      
- 
        Number of holders
      
- 
        363
      
      
- 
        Total 13F shares, excl. options
      
- 
        83.3M
      
      
- 
        Shares change
      
- 
        +505K
      
      
- 
        Total reported value, excl. options
      
- 
        $4.82B
      
      
- 
        Value change
      
- 
        +$32.6M
      
      
- 
        Put/Call ratio
      
- 
        1.3
      
      
- 
        Number of buys
      
- 
        198
      
      
- 
        Number of sells
      
- 
        -135
      
      
- 
        Price
      
- 
        $57.82
      
 
     
   
 
  
    Significant Holders of RESMED INC - Common Stock (RMD) as of Q1 2016
  
    
      410  filings reported holding RMD - RESMED INC - Common Stock as of Q1 2016.
      
        RESMED INC - Common Stock (RMD) has 363 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
        These institutions hold a total of 83.3M shares
          of 146M outstanding shares and own 56.9% of the company stock.
        
        Largest 10 shareholders include VANGUARD GROUP INC (10.6M shares), Capital World Investors (6.97M shares), FMR LLC (5.98M shares), BlackRock Fund Advisors (5.19M shares), STATE STREET CORP (4.48M shares), BlackRock Institutional Trust Company, N.A. (4.27M shares), Bank of New York Mellon Corp (2.48M shares), Commonwealth Bank of Australia (2.03M shares), PRUDENTIAL PLC (1.29M shares), and RENAISSANCE TECHNOLOGIES LLC (1.28M shares).
        
        This table shows the top 363 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
    
  
    
      
        
          | Investor | Option | Weight % | Change % | Value $ | * Price $ | Shares | Share Change | Activity | Report Period | 
      
      
      
    
   
  * Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
    An asterisk sign (*) next to the price indicates that the price is likely invalid.